Last Updated : September 18, 2009
Details
FilesGeneric Name:
Dronedarone hydrochloride
Project Status:
Complete
Therapeutic Area:
Atrial fibrillation
Manufacturer:
Sanofi-Aventis Canada Inc.
Brand Name:
Multaq
Project Line:
Reimbursement Review
Project Number:
SR0177-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Atrial fibrillation
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : September 18, 2009